Hepatitis C virus genotype 1
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
OBJECTIVES
INSIGHT (ClinicalTrials.gov NCT01513941) evaluated the efficacy, safety and pharmacokinetics of telaprevir-based…
AIM
To examined the efficacy and safety of treatment with boceprevir, PEGylated-interferon and ribavirin (PR) in hepatitis C…
While genetic polymorphisms upstream of the interleukin‐28B (IL28B) gene are associated with necroinflammatory activity grade in…
Background The length of treatment with triple therapy against hepatitis C virus genotype 1 (HCV-1), which comprises telaprevir…
In the United States, dual therapy with pegylated interferon (Peg-IFN) and ribavirin had been the standard treatment for chronic…
Background The addition of telaprevir to standard treatment considerably improves response rates and allows the duration of…